Developing a New Approach to Treat Rare, Autoimmune Conditions

Jodi Karnell, senior director of Research at Horizon Therapeutics, discusses the role of plasmacytoid dendritic cells in certain autoimmune conditions, how the company’s experimental therapy daxdilimab works, and why it may offer a way to address a range of rare autoimmune condition for which there are no approved therapies or that are poorly addressed by existing treatment options.